tiprankstipranks
Trending News
More News >
ImageneBio (IMA)
NASDAQ:IMA
US Market

ImageneBio (IMA) Financial Statements

Compare
109 Followers

ImageneBio Financial Overview

ImageneBio's market cap is currently $80.82M. The company's EPS TTM is $; its P/E ratio is -0.84; ImageneBio is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 3.50M$ 9.16M$ 15.62M$ 30.98M$ 9.19M
Gross Profit$ 3.50M$ 8.14M$ -48.70M$ -16.12M$ -35.65M
Operating Income$ -37.00M$ -75.42M$ -70.90M$ -34.14M$ -44.52M
EBITDA$ -35.47M$ -74.40M$ -70.15M$ -33.59M$ -44.22M
Net Income$ -36.57M$ -68.17M$ -68.77M$ -34.12M$ -44.26M
Balance Sheet
Cash & Short-Term Investments$ 124.39M$ 175.47M$ 156.95M$ 232.22M$ 162.49M
Total Assets$ 141.51M$ 192.09M$ 172.26M$ 247.88M$ 168.40M
Total Debt$ 7.52M$ 10.74M$ 5.69M$ 6.99M$ 186.00K
Net Debt$ -31.87M$ -109.16M$ -54.23M$ -225.23M$ -162.31M
Total Liabilities$ 15.58M$ 22.34M$ 25.29M$ 40.00M$ 269.45M
Stockholders' Equity$ 125.93M$ 169.76M$ 146.97M$ 207.88M$ -101.05M
Cash Flow
Free Cash Flow$ -46.00M$ -80.16M$ -75.54M$ -62.01M$ -38.59M
Operating Cash Flow$ -46.00M$ -79.74M$ -74.11M$ -60.25M$ -37.83M
Investing Cash Flow$ -34.90M$ 64.14M$ -99.28M$ -1.76M$ 2.92M
Financing Cash Flow$ 0.00$ 75.98M$ 1.09M$ 131.74M$ 116.18M
Currency in USD

ImageneBio Earnings and Revenue History

ImageneBio Debt to Assets

ImageneBio Cash Flow

ImageneBio Forecast EPS vs Actual EPS